Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics.
about
Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women.Immunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF.Involvement of DNA-PKcs in the IL-6 and IL-12 response to CpG-ODN is mediated by its interaction with TRAF6 in dendritic cells.Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners.Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic realityAntisense-based cancer therapeutics: are we there yet?Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxinAntisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic dissemination.Alternate dab-aegPNAs: synthesis, nucleic acid binding studies and biological activity.CpG and Non-CpG oligodeoxynucleotides induce differential proinflammatory gene expression profiles in liver and peripheral blood leukocytes in mice.Toll-Like Receptor 9 Agonists for Cancer Therapy.
P2860
Q33579661-9EEEC903-BADE-4A51-A107-8DF014E8BA58Q33960866-2FE59162-B7B7-4C9C-8A4D-DFF7B42429C6Q34637635-8E3CF72C-5822-4A88-8863-A1529C46B2FDQ35587718-29CA0C5C-953C-4CA8-BD14-8CBCC48F1529Q36326572-9947B84E-523B-49ED-BBCB-83434BA756FBQ36458427-4690D636-B434-400A-B169-F1ED3B809688Q36593534-6F4F6A58-B701-4E95-A73D-3B15E59907D5Q37189998-C54A0ECF-A72F-4DFE-835E-2B5B2938FBB6Q37335260-518C875D-F463-4F74-B416-8AE9D7FC16E7Q38347792-FEA15F00-ACB8-4810-8EF2-E9C534AAF38DQ46796731-6544C346-D761-40AA-AC97-5C2E2C14D5A3Q50863800-F54CBD38-EFFE-40BB-8DA4-317995B00637
P2860
Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Synthetic oligodeoxynucleotide ...... novel anticancer therapeutics.
@ast
Synthetic oligodeoxynucleotide ...... novel anticancer therapeutics.
@en
type
label
Synthetic oligodeoxynucleotide ...... novel anticancer therapeutics.
@ast
Synthetic oligodeoxynucleotide ...... novel anticancer therapeutics.
@en
prefLabel
Synthetic oligodeoxynucleotide ...... novel anticancer therapeutics.
@ast
Synthetic oligodeoxynucleotide ...... novel anticancer therapeutics.
@en
P50
P356
P1476
Synthetic oligodeoxynucleotide ...... novel anticancer therapeutics.
@en
P304
P356
10.2174/1381612054546707
P577
2005-01-01T00:00:00Z